Results 201 to 210 of about 41,535 (224)
Some of the next articles are maybe not open access.
Chemoembolization and radioembolization
Best Practice & Research Clinical Gastroenterology, 2014Chemoembolization and radioembolization are at the core of the treatment of patients with hepatocellular carcinoma who cannot receive potentially curative therapies such as transplantation, resection or percutaneous ablation. They differ in the mechanism of action (ischaemia and increase cytotoxic drug exposure for chemoembolization, internal ...
openaire +2 more sources
Chemoembolization of Hepatocellular Carcinoma
Journal of Vascular and Interventional Radiology, 2002Transcatheter arterial chemoembolization (TACE) is the mainstay of treatment for patients with unresectable hepatocellular carcinoma (HCC). Chemoembolization involves delivery of some type of chemotherapy combined with some type of arterial embolization to destroy tumor cells. Whereas diffuse tumors may require lobar embolization, smaller tumors may be
Douglas E, Ramsey +3 more
openaire +2 more sources
Transarterial Chemoembolization and Radioembolization
Seminars in Liver Disease, 2014Transarterial chemoembolization (TACE) and radioembolization (RE) are frequently used to treat patients with hepatocellular carcinoma who cannot receive curative therapies. Transarterial chemoembolization is a heterogeneous group of procedures; based on two positive clinical trials and three meta-analyses, conventional TACE is the standard of care for ...
Bruno, Sangro, Riad, Salem
openaire +2 more sources
Chemoembolization: principles and perspectives
Journal of Microencapsulation, 1984Chemoembolization is the injection of active-principle-bearing microparticles via selective catheterization. The authors discuss the advantages and the possibilities of this method in relation to selective catheterization and to the various time periods required for microparticle biodegradation and the kinetics of drug release.
P, Madoule, P, Trampont, A, Roche
openaire +2 more sources
Chemoembolization for Hepatocellular Carcinoma
Seminars in Oncology, 2012Transcatheter arterial chemoembolization (TACE) is the standard of care for patients with preserved liver function and asymptomatic, noninvasive multinodular hepatocellular carcinoma (HCC) confined to the liver. However, the survival benefit of conventional TACE-including the administration of an anticancer agent-in-oil emulsion followed by embolic ...
openaire +3 more sources
Chemoembolization of hepatic malignancy
Abdominal Imaging, 2008Treatment of primary and secondary hepatic malignancies with transarterial chemoembolization represents an essential component of interventional oncology. This article discusses patient selection, procedure technique, results, and complications associated with transarterial chemoembolization.
Carin F, Gonsalves, Daniel B, Brown
openaire +2 more sources
Chemoembolization Plus Ablation: Current Status
Seminars in Interventional Radiology, 2023AbstractHepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide. The treatment landscape for HCC has evolved significantly over the past decade, with several modalities available to treat various stages of disease. The Barcelona Clinic Liver Cancer (BCLC) system provides a foundation for treatment guidance.
Farnaz, Dadrass +2 more
openaire +2 more sources
Chemoembolization for hepatic metastases
Techniques in Vascular and Interventional Radiology, 2002Liver metastases are one of the most difficult therapeutic challenges in modern oncologic practice. Few systemic therapies are effective for solid tumors in the liver. Resection is possible in a minority of patients and usually not curative. Image-guided therapies such as chemoembolization offer substantial intensification of treatment by combining ...
Michael, Gee, Michael C, Soulen
openaire +2 more sources